Latest posts
-
CBD, Delta-9 THC, and Total THC on Hemp Labels: A Serving-Math Guide
By TakeHempGummies.com Consumer Research Desk — Updated September 10, 2026 You’re standing in your kitchen holding two different labels One bag says “25 mg CBD per gummy.” Another says “Total THC: 0.8 mg per gummy, Delta-9 THC: 0.6 mg per gummy.” A third lists only “Hemp Extract Blend” with no numbers at all. This guide…
-
Hemp Gummy Subscription Terms: How to Check Auto-Ship, Cancellation and Renewal Rules
How to Check Hemp Gummy Subscription Terms Before You Buy Hemp gummy subscription terms are the checkout disclosures that explain how a seller will bill you again, when a trial or promotional period ends, and how you can cancel before the next shipment. Reading them before you pay, and saving a copy afterward, gives you…
-
Hemp Gummies and Digestive Symptoms: IBS Marketing vs Available Research
Do Hemp Gummies Actually Help IBS and Digestive Symptoms? No hemp or CBD gummy is approved to treat irritable bowel syndrome (IBS) or any other digestive condition. Marketing language that suggests otherwise is running ahead of the science. Federal health agencies say research on cannabinoids and the gut is still early, and IBS itself needs…
-
Raw Cannabinoids: What CBDa and THCa Are and Why They Need Different Evaluation
What Are CBDa and THCa? CBDa (cannabidiolic acid) and THCa (tetrahydrocannabinolic acid) are the raw, acidic forms of CBD and THC that exist naturally in the fresh, unheated cannabis or hemp plant. The plant does not produce CBD or THC directly. It produces these acidic precursors first, and heat converts them into the more familiar…
-
CBD and Inflammatory Conditions: Arthritis Claims and Evidence Boundaries
Does CBD Help With Arthritis and Joint Inflammation? Right now, the honest answer is: nobody knows for sure. Most research on CBD and inflammation comes from animal studies and small, short human trials — not the kind of large, long-term studies needed to prove a product works for arthritis. The National Center for Complementary and…
-
Hemp Gummies and Seizure Context: Epidiolex vs OTC CBD Products
Epidiolex vs. Hemp Gummies: What’s the Real Difference for Seizures? Epidiolex is the only cannabidiol (CBD) product the FDA has approved as a medicine, and it’s approved specifically to treat seizures linked to three rare epilepsy conditions. Hemp gummies sold online or in stores are not approved to treat, prevent, or control seizures of any…
-
CBG (Cannabigerol): The Emerging Cannabinoid and Its Early Research Profile
What Is CBG and What Does the Research Actually Show? Cannabigerol, or CBG, is one of more than 100 cannabinoids found in the cannabis plant. It does not cause a high. Right now, human research on CBG by itself is very limited, and no CBG product has FDA approval for treating any condition. Most of…
-
CBD and Migraines: What Headache Research Shows and What Remains Unknown
Does CBD Help Migraines? Here’s What the Evidence Actually Shows Right now, there is no CBD-specific clinical trial proving that CBD reduces migraine attacks. Most human cannabinoid research on pain conditions has studied products containing THC, cannabis’s psychoactive compound, or a combination of THC and CBD, rather than CBD by itself. If you have migraines…
-
Hemp Gummies and Focus: ADHD Marketing vs Available Evidence
Do Hemp Gummies Help With Focus or ADHD? No major federal health agency has found that hemp gummies improve focus or treat ADHD symptoms. The National Institutes of Health’s own summary of cannabis and cannabinoid research does not list attention, focus, or ADHD among the conditions it has studied at all. This article explains what…
-
CBN Gummies for Sleep: Separating Marketing Claims From Available Science
Do CBN Gummies Actually Work for Sleep? CBN, short for cannabinol, is a minor cannabinoid found in the hemp plant that some brands market as a natural sleep aid. Right now, there is no large body of published human research that directly tests CBN gummies for sleep, and no federal health agency has approved a…